| Help | Sign in | |||
|
|
| Discussions for Tongjitang Chinese Medicines Co. |
|
| Upcoming presentation of a small cap company's Alzheimer's drug data in July
A small cap company is going to be presenting data on their Alzheimer's drug at the Alzheimer's conference in July. If the trials data is positive, it brings the company one step closer to the approval of a breakthrough treatment for Alzheimer's disease. To find out about the company, the drug, how the drug works, who are the other... debapriyadutta - |
| Phase III trial data of a small cap company's upcoming obesity drug
Small cap company to release Phase 3 data on their Obesity drug. If results are good, it will result in huge interest in the company and its stock. To read about which company, what drug, how it targets obesity, how its different from existing drugs targeting obesity, estimated market penetration of approved, etc., get a FREE report at:... sneha - |
| Upcoming Phase 3 data of Obesity drug
Small cap company to release Phase 3 data on their Obesity drug. If results are good, it will result in huge interest in the company and its stock. To read about which company, what drug, how it targets obesity, how its different from existing drugs targeting obesity, estimated market penetration of approved, etc., get a FREE report at:... kamalika4321 - |
| FDA Decision on approval of a small cap company's drug for Anemia on June 29th
Upcoming FDA Decision date on JUNE 29th (TODAY) for this small cap company's drug for Anemia patients. If the FDA approves this drug, it could become the gold standard for iron deficiency in anemic patients who have chronic kidney disease. To read about our opinion on whether the drug will be approved or not, along with details of the company,... rdpc - |
| Upcoming FDA Approval of a small cap company's drug for Anemia patients
Upcoming FDA Decision date on JUNE 29th (Monday) for this small cap company's drug for Anemia patients. If the FDA approves this drug, it could become the gold standard for iron deficiency in anemic patients who have chronic kidney disease. To read about our opinion on whether the drug will be approved or not, along with details of the company,... ritushreeya - |
| Upcoming FDA Decision on June 29th on approval of a small cap company's drug for Anemia patients
Upcoming FDA Decision date on JUNE 29th (Monday) for this small cap company's drug for Anemia patients. If the FDA approves this drug, it could become the gold standard for iron deficiency in anemic patients who have chronic kidney disease. To read about our opinion on whether the drug will be approved or not, along with details of the company,... debapriyadutta - |
| Upcoming Clinical Trials data of a small cap company's Alzheimer's drug to be presented in July
A small cap company is going to be presenting data on their Alzheimer's drug at the Alzheimer's conference in July. If the trials data is positive, it brings the company one step closer to the approval of a breakthrough treatment for Alzheimer's disease. To find out about the company, the drug, how the drug works, who are the other... ritushreeya - |
| Upcoming FDA Panel recommendation on June 26th of a small cap company's Opthalmic (eye) drug
FDA Panel meeting on Friday (June 26th) to recommend approval on a small cap company's opthalmic drug. If the drug is eventually approved, the Peak Sales of this drug could reach over 100% of the current market cap of the company. To read about the drug, the disease, the market, and how the drug compares to competitors, get a... debapriyadutta - |
| Upcoming FDA decision on the approval of a small cap company's Depression drug
The FDA approval decision date for a small cap company's Depression drug is coming up in July. If approved, this could become a breakthrough treatment for Depression and take a sizable bite out of major players like Forest Labs and Wyeth's market share. To find out what the chances are of this new drug being approved, how the drug... tanu - |
| A FREE report on upcoming FDA approval of AMAG's Feraheme
The FDA will make a decision on the approval of an iron deficiency drug shortly. This drug had been turned down by the FDA in its last 2 attempts of getting approval. Will this time be different? Will the company finally manage to get one of its key pipeline drugs approved? To read about our opinion on the upcoming FDA decision and to find out... debapriyadutta - |
| Discussions 1 - 10 of 41 Older » | |
| XML |
| Google Home - Terms of Service - Privacy Policy |
©2009 Google